# P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p082-cbcsg-10-the-addition-of-capecitabine-to-adjuvant-chemotherapy-in-triple/

## Facts

| Field | Value |
| --- | --- |
| Author Names | J. Li,Z. Shao,S. Yang,Jun Jiang,Chengyou Wang,Ye Liu,Peifen Fu,D. Pang,Y. Sheng |
| Citations | 1 |
| DOI | 10.1016/s0960-9776(15)70127-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/s0960-9776(15)70127-x |
| OpenAlex ID | https://openalex.org/W2088217612 |
| Type | conference-abstract |
| Year | 2015 |

## Paper authors

- [Ye Liu](https://scholariq.org/researchers/ye-liu/)

## Paper journal

- [The Breast](https://scholariq.org/journals/the-breast/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.